Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Deliver on the promises of the past and create smart solutions for the future.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
In the past few years, Milliman has advised on more than $25 billion in structured finance insurance solutions, participating in most of the securitisation transactions and many privately funded and letter-of-credit transactions. This field, which provides insurance companies with more flexibility in managing capital, is complex and rapidly developing. Companies know they can turn to us for up-to-date information, industry-leading experience, and unbiased, fiscally sound guidance.
Our clients include insurers, reinsurers, banks, and financial guarantors, all of whom rely on us for accurate cash-flow projections, as well as thorough deal and portfolio risk analysis. We are experienced in a wide variety of structured finance, including securitisations, private or bank-financed deals, and warehouse deals.
We have the experience to assist our clients with appropriate solutions and all associated risks. We are well-versed in all types of structured finance insurance solutions, including:
Milliman assisted an insurer in evaluating alternative ways to fund redundant reserves. After the insurer decided to use a securitisation solution, Milliman developed assumptions and models for the level-term business included in the securitisation, including development of economic reserves. Our projections included baseline projections as well as a range of stress tests. The results from our work were documented in a report that was included in the offering circular for the transaction. We developed a separate report, reviewing the transaction "deal model". We also participated in discussions with the rating agencies, the regulators, the financial guarantors, and potential investors, on behalf of our client.
Ask the tough questions. We’re ready for them.